Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 17:8:1753-60.
doi: 10.2147/OTT.S86136. eCollection 2015.

IL-2 -330T/G polymorphism and cancer risk: a meta-analysis

Hongyu Zhao  1 , Rui Wang  2
Affiliations

IL-2 -330T/G polymorphism and cancer risk: a meta-analysis

Hongyu Zhao et al. Onco Targets Ther. .

Abstract

Purpose: Some studies have investigated the association of IL-2 -330T/G (rs2069762) polymorphism with cancer risk, but the previous results were conflicting and had relatively low statistical power. Thus, we performed a meta-analysis to derive a more precise estimation of the association between IL-2 -330T/G polymorphism and cancer risk.

Methods: A literature search was performed systematically using electronic databases. The odds ratio (OR) with 95% confidence interval (CI) was used to estimate the pooled effect.

Results: A total of ten studies including 3,060 cases and 3,435 controls were involved in this meta-analysis. The results indicated that IL-2 -330T/G polymorphism was significantly associated with cancer risk ([OR =2.03, 95% CI =1.40-2.95] for GG vs TT; [OR =1.37, 95% CI =1.11-1.69] for GT vs TT; [OR =1.46, 95% CI =1.18-1.81] for [GG + GT] vs TT; [OR =1.66, 95% CI =1.24-2.23] for GG vs [GT + TT]; and [OR =1.35, 95% CI =1.16-1.57] for G vs T). In the subgroup analysis according to cancer type, significant association was found in lymphoma ([OR =1.46, 95% CI =1.11-1.91] for GT vs TT; [OR =1.58, 95% CI =1.22-2.05] for [GG + GT] vs TT; [OR =1.84, 95% CI =1.22-2.77] for GG vs [GT + TT]) and other cancers, but not in gastric cancer. In the subgroup analysis by ethnicity, the significant risk was found among Asians, but not among Europeans.

Conclusion: This meta-analysis suggests that IL-2 -330T/G polymorphism has an increased risk of cancer in Asians. However, further detailed studies are still required to confirm our findings.

Keywords: IL-2; cancer; meta-analysis; polymorphism; risk.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The flow chart of article selection.
Figure 2
Figure 2
Forest plots representing the pooled results of ORs for the association between IL-2 -330T/G polymorphism and overall cancer risk. Note: Weights are from random effect analysis. Abbreviations: CI, confidence interval; OR, odds ratio.
Figure 3
Figure 3
The sensitivity analysis results of IL-2 -330T/G polymorphism with overall cancer risk. Abbreviation: CI, confidence interval.
Figure 4
Figure 4
Begg’s funnel plots of IL-2 -330T/G polymorphism with overall cancer risk. Abbreviations: OR, odds ratio; SE, standard error.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. - PubMed
    1. Nelson BH. IL-2, regulatory T cells, and tolerance. J Immunol. 2004;172(7):3983–3988. - PubMed
    1. Abbas KA. Cellular and Molecular Immunology. 5th ed. Philadelphia, PA: Saunders Elsevier; 2005.
    1. Miyazaki T, Liu ZJ, Kawahara A, et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell. 1995;81(2):223–231. - PubMed
    1. Wang R, Ciardelli TL, Russell JH. Partial signaling by cytokines: cytokine regulation of cell cycle and Fas-dependent, activation-induced death in CD4+ subsets. Cell Immunol. 1997;182(2):152–160. - PubMed